piracetam has been researched along with Brain Hemorrhage in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is a reasonable alternative to (fos)phenytoin for prophylaxis of early posthemorrhagic seizures." | 3.80 | Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage. ( Bansal, S; Blalock, D; Carpenter, JL; Dean, NP; Kebede, T, 2014) |
| "Despite similarities in hemorrhage type and severity at onset, patients receiving levetiracetam had better cognition at discharge and fewer seizures than patients receiving phenytoin." | 3.77 | Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage. ( Ehtisham, A; Heinrichs, RJ; Janzen, JM; Taylor, S, 2011) |
| " CASE REPORT We report the levetiracetam pharmacokinetic profile of a patient being treated with levetiracetam 1000 mg intravenously every 12 h who required continuous veno-venous hemofiltration (CVVH)." | 1.46 | Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration. ( Cava, LF; Fish, DN; Kiser, TH; MacLaren, R; Mueller, SW; Neumann, RT; Van Matre, ET, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Matre, ET | 1 |
| Mueller, SW | 1 |
| Fish, DN | 1 |
| MacLaren, R | 1 |
| Cava, LF | 1 |
| Neumann, RT | 1 |
| Kiser, TH | 1 |
| Bansal, S | 1 |
| Blalock, D | 1 |
| Kebede, T | 1 |
| Dean, NP | 1 |
| Carpenter, JL | 1 |
| Taylor, S | 1 |
| Heinrichs, RJ | 1 |
| Janzen, JM | 1 |
| Ehtisham, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China[NCT02550028] | Phase 1/Phase 2 | 60 participants (Actual) | Interventional | 2015-09-01 | Terminated (stopped due to The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for piracetam and Brain Hemorrhage
| Article | Year |
|---|---|
Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.
Topics: Aged; Anticonvulsants; Hemofiltration; Humans; Intracranial Hemorrhages; Levetiracetam; Male; Pirace | 2017 |
Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Incidence; Infant; Intracrania | 2014 |
Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Cognition Disorders; Female; Humans; Intracranial H | 2011 |